{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:05:32Z","timestamp":1790280332599,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.ijantimicag.2008.05.018","type":"journal-article","created":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T09:48:31Z","timestamp":1220262511000},"page":"411-417","source":"Crossref","is-referenced-by-count":17,"title":["Therapeutic effect of rokitamycin in vitro and on experimental meningoencephalitis due to Naegleria fowleri"],"prefix":"10.1016","volume":"32","author":[{"given":"Jong-Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Jin","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Ju","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daeho","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung-Hee","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Il","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Joon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2008.05.018_bib1","first-page":"740","article-title":"Acute pyogenic meningoencephalitis probably due to Acanthamoeba sp.: a preliminary report","volume":"3","author":"Fowler","year":"1965","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1700960102","article-title":"Primary amoebic meningoencephalitis: clinical, pathological and epidemiological features of six fatal cases","volume":"96","author":"Carter","year":"1968","journal-title":"J Pathol Bacteriol"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/path.1711000402","article-title":"Description of a Naegleria species isolated from two cases of primary amoebic meningoencephalitis and of the experimental pathological changes induced by it","volume":"100","author":"Carter","year":"1970","journal-title":"J Pathol"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0035-9203(72)90147-2","article-title":"Primary amoebic meningoencephalitis. An appraisal of present knowledge","volume":"66","author":"Carter","year":"1972","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/0035-9203(82)90141-9","article-title":"Comparative sensitivity of Naegleria fowleri to amphotericin B and amphotericin B methyl ester","volume":"76","author":"Ferrante","year":"1982","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib6","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.ijpara.2004.06.004","article-title":"Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals","volume":"34","author":"Schuster","year":"2004","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib7","first-page":"876","article-title":"Effect of antifungal drugs on pathogenic Naegleria spp. isolated from natural water sources","volume":"86","author":"Tiewcharoen","year":"2003","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib8","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1128\/AAC.48.12.4520-4527.2004","article-title":"In vitro evaluation of the effectiveness of the macrolide rokitamycin and chlorpromazine against Acanthamoeba castellanii","volume":"48","author":"Mattana","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1128\/AAC.47.2.524-528.2003","article-title":"Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis","volume":"17","author":"Goswick","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1550-7408.2005.00082.x","article-title":"In vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri","volume":"53","author":"Schuster","year":"2006","journal-title":"J Eukaryot Microbiol"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib11","first-page":"581","article-title":"Amphotericin B\u2014specifics of administration","volume":"7","author":"Goodman","year":"1970","journal-title":"Mod Treat"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJM196801182780302","article-title":"Renal tubular acidosis due to amphotericin B","volume":"278","author":"McCurdy","year":"1968","journal-title":"N Engl J Med"},{"issue":"Suppl B","key":"10.1016\/j.ijantimicag.2008.05.018_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jac\/28.suppl_B.49","article-title":"Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents","volume":"28","author":"Proffitt","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/infdis\/143.2.193","article-title":"Primary amoebic meningoencephalitis: a report of two cases and antibiotic and immunologic studies","volume":"143","author":"Stevens","year":"1981","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib15","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1128\/AAC.32.11.1710","article-title":"Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides","volume":"32","author":"Hardy","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0732-8893(92)90055-X","article-title":"Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overview","volume":"15","author":"Hardy","year":"1992","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0005-2787(78)90287-3","article-title":"Studies on the mode of action of hygromycin B, an inhibitor of translocation in eukaryotes","volume":"521","author":"Gonzalez","year":"1978","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1128\/MMBR.51.3.341-350.1987","article-title":"Mechanism of bactericidal action of aminoglycosides","volume":"51","author":"Davis","year":"1987","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0732-8893(83)90035-4","article-title":"Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials","volume":"1","author":"Jones","year":"1983","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1179\/joc.2002.14.2.115","article-title":"Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14- and 15-membered ring macrolides","volume":"14","author":"Braga","year":"2002","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0168-1656(91)90026-R","article-title":"Proteolytic events in the processing of secreted proteins in fungi","volume":"17","author":"Calmels","year":"1991","journal-title":"J Biotechnol"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib22","first-page":"701","article-title":"Isolement et culture in vitro des amibes de genre Naegleria","volume":"51","author":"Willaert","year":"1971","journal-title":"Ann Soc Belg Med Trop"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3347\/kjp.2004.42.1.35","article-title":"Decreasing effect of an anti-Nfa1 polyclonal antibody on the in vitro cytotoxicity of pathogenic Naegleria fowleri","volume":"42","author":"Jeong","year":"2004","journal-title":"Korean J Parasitol"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.arcmed.2004.11.003","article-title":"Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous amphotericin B, fluconazole and rifampicin","volume":"36","author":"Vargas-Zepeda","year":"2005","journal-title":"Arch Med Res"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0303-8467(93)90132-Z","article-title":"Successful treatment of amoebic meningoencephalitis in a Chinese living in Hong Kong","volume":"95","author":"Wang","year":"1993","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1645\/GE-87R","article-title":"Activities of therapeutic agents against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis","volume":"89","author":"Goswick","year":"2003","journal-title":"J Parasitol"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib27","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.2307\/3284060","article-title":"In vivo study of artemisinin and its derivatives against primary amebic meningoencephalitis caused by Naegleria fowleri","volume":"81","author":"Gupta","year":"1995","journal-title":"J Parasitol"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib28","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0022-3565(24)36687-X","article-title":"Expression of hygR in transgenic mice causes resistance to toxic effects of hygromycin B in vivo","volume":"281","author":"Aubrecht","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib29","first-page":"830","article-title":"A study of antichlamydial effect of rokitamycin","volume":"41","author":"Soejima","year":"1988","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib30","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1128\/AAC.39.5.1185","article-title":"In vitro activity of rokitamycin, a new macrolide, against Borrelia burgdorferi","volume":"39","author":"Cinco","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0924-8579(03)00007-4","article-title":"Treatment with rokitamycin suppresses the lethality in a murine model of Escherichia coli O157:H7 infection","volume":"21","author":"Hiramatsu","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib32","first-page":"621","article-title":"Rokitamycin tolerance in patients with adverse reactions to chemotherapeutic agents","volume":"147","author":"Cenci","year":"1996","journal-title":"Clin Ter"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib33","first-page":"739","article-title":"Studies on plasma levels and clinical efficacy of rokitamycin in pediatrics","volume":"41","author":"Yamashita","year":"1988","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.ijantimicag.2008.05.018_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF03189950","article-title":"Pharmacokinetics of rokitamycin after single administration to healthy volunteers","volume":"16","author":"Broggini","year":"1991","journal-title":"Eur J Drug Metab Pharmacokinet"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857908002641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857908002641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T19:36:44Z","timestamp":1738352204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857908002641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0924857908002641"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2008.05.018","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}